Buprenorphine in the Treatment of Opioid Dependence

Home    >   Qualifying for Office-Based Buprenorphine Treatment  

Qualifying for Office-Based Buprenorphine Treatment

The Drug Addiction Treatment Act of 2000 expanded treatment for opiate dependence into mainstream medical practice. It specifies several ways in which physicians can qualify to prescribe and dispense buprenorphine in their offices for the treatment of opioid dependence. Some will need to complete training prior to notifying the U.S. Department of Health and Human Services (DHHS) of their intention to prescribe buprenorphine for opioid dependence. The American Academy of Addiction Psychiatry has been designated by law to provide such training. This online course meets the 8 hour requirement specified in the Act.

This program is designed for physicians who are likely to treat opiate-dependent persons in their practice, such as those in family practice, general internal medicine, psychiatry, pediatrics, and adolescent medicine specialists. This online training is especially valuable for:

  • Physicians and other primary care providers who are not addiction specialists and who would like to provide treatment for opiate-addicted patients.


  • Addiction specialists who provide treatment for opiate addiction and who want to increase treatment options.


  • Addiction specialists who have not treated opiate addiction in their practices, but who want to learn how to do so.


  • Addiction specialists who want to supplement face-to-face training, refresh their memory, review specific areas, or to review the elements involved in implementing buprenorphine in the context of office-based treatment.
back   top next

Site Map  |   HHS Privacy Statement  |  Contact Us  |  Danya Learning Center
Developed by the American Academy of Addiction Psychiatry and Danya International with funding from the Center for Substance Abuse Treatment.
Last updated: September 20, 2002.